REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cubist Systematic Strategies, LLC 173,686$5,594,4260.03%
Yarbrough Capital, LLC 12,203$393,0590.03%
Orbimed Advisors 50,000$1,610,5000.03%
GILDER GAGNON HOWE & CO LLC 55,517$1,788,2030.03%
CIBC Asset Management Inc 226,668$7,300,9760.03%
Man Group plc 249,774$8,045,2210.03%
LORD, ABBETT & CO. LLC 231,776$7,4650.03%
ALLIANCEBERNSTEIN L.P. 1,978,557$63,729,3210.03%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 165,026$5,315,4870.03%
Freestone Capital Holdings, LLC 18,020$580,4240.03%
Perfromance Wealth Partners, LLC 15,500$499,2550.03%
Connor, Clark & Lunn Investment Management Ltd. 131,452$4,234,0690.02%
VICTORY CAPITAL MANAGEMENT INC 598,685$19,283,6440.02%
Assenagon Asset Management S.A. 194,911$6,278,0830.02%
Centiva Capital, LP 26,200$843,9020.02%
HighTower Advisors, LLC 305,259$9,830,0000.02%
Dynamic Technology Lab Private Ltd 6,840$2200.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 20,214$651,0930.02%
JPMORGAN CHASE & CO 5,164,157$166,338,0000.02%
MACROVIEW INVESTMENT MANAGEMENT LLC 359$11,5640.02%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.